Vigil Neuroscience, Inc.
VIGL
Cena:
Valuace
70
Růst
0
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
VIGIL NEUROSCIENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VIGIL NEUROSCIENCE, INC. - VIGL
14-07-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde
SHAREHOLDER INVESTIGATION: HALPER SADEH LLC INVESTIGATES HURA AND VIGL ON BEHALF OF SHAREHOLDERS
09-06-2025
NEW YORK , JUNE 9, 2025 /PRNEWSWIRE/ -- HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGAT...
Více zde
VIGIL SHAREHOLDER ALERT: KASKELA LAW LLC ANNOUNCES INVESTIGATION INTO FAIRNESS OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL) PROPOSED SHAREHOLDER BUYOUT AND ENCOURAGES INVESTORS TO CONTACT THE FIRM
04-06-2025
PHILADELPHIA , JUNE 4, 2025 /PRNEWSWIRE/ -- THE LAW FIRM OF KASKELA LAW LLC ANNOUNCES THAT IT IS IN...
Více zde
VIGIL NEUROSCIENCE PROVIDES UPDATE ON ILUZANEBART PHASE 2 IGNITE TRIAL IN ALSP
04-06-2025
WATERTOWN, MASS., JUNE 04, 2025 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINI...
Více zde
$HAREHOLDER ALERT: CLASS ACTION ATTORNEY JUAN MONTEVERDE INVESTIGATES THE MERGER OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL)
24-05-2025
NYC, MAY 24, 2025 (GLOBE NEWSWIRE) -- NEW YORK, MAY 24, 2025 / GLOBENEWSWIRE/ -- CLASS ACTION ATTORN...
Více zde
VIGIL NEUROSCIENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VIGIL NEUROSCIENCE, INC. - VIGL
22-05-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde
SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER VIGIL NEUROSCIENCE INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS
22-05-2025
MILWAUKEE--(BUSINESS WIRE)--THE ADEMI FIRM IS INVESTIGATING VIGIL (NASDAQ: VIGL) FOR POSSIBLE BREACH...
Více zde
VIGL STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF VIGIL NEUROSCIENCE, INC. IS FAIR TO SHAREHOLDERS
21-05-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde
VIGIL NEUROSCIENCE ENTERS INTO DEFINITIVE MERGER AGREEMENT TO BE ACQUIRED BY SANOFI
21-05-2025
- VIGIL'S SHAREHOLDERS TO RECEIVE UP TO $10.00 PER SHARE IN CASH, COMPRISED OF $8.00 PER SHARE IN CA...
Více zde
VIGIL NEUROSCIENCE REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS UPDATES
07-05-2025
– ON TRACK TO REPORT FINAL ANALYSIS FROM IGNITE PHASE 2 CLINICAL TRIAL EVALUATING ILUZANEBART IN A...
Více zde
VIGIL NEUROSCIENCE PRESENTS DATA ON ITS SMALL MOLECULE TREM2 AGONIST VG-3927 IN TWO ORAL PRESENTATIONS AT AD/PD™ 2025 INTERNATIONAL CONFERENCE
02-04-2025
- PRECLINICAL PRESENTATION HIGHLIGHTS KEY, MODALITY SPECIFIC, PHARMACOLOGICAL DIFFERENTIATIONS OF VG...
Více zde
VIGIL NEUROSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS UPDATES
13-03-2025
– ANNOUNCED POSITIVE DATA FROM PHASE 1 CLINICAL TRIAL EVALUATING VG-3927 FOR POTENTIAL TREATMENT O...
Více zde
VIGIL NEUROSCIENCE TO PRESENT AT THE STIFEL 2025 VIRTUAL CNS FORUM
11-03-2025
WATERTOWN, MASS., MARCH 11, 2025 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLIN...
Více zde
SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL)
20-02-2025
NEW YORK , FEB. 20, 2025 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING ...
Více zde
VIGIL NEUROSCIENCE TO PRESENT AT GUGGENHEIM SECURITIES SMID CAP BIOTECH CONFERENCE
30-01-2025
WATERTOWN, MASS., JAN. 30, 2025 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINI...
Více zde
VIGIL NEUROSCIENCE REPORTS POSITIVE DATA FROM ITS PHASE 1 CLINICAL TRIAL EVALUATING VG-3927 FOR THE POTENTIAL TREATMENT OF ALZHEIMER'S DISEASE
23-01-2025
- SAFETY, TOLERABILITY, PHARMACOKINETIC, AND PHARMACODYNAMIC PROFILE SUPPORTS CONTINUED DEVELOPMENT ...
Více zde
VIGIL NEUROSCIENCE HIGHLIGHTS 2024 CORPORATE ACHIEVEMENTS AND UPCOMING 2025 MILESTONES
08-01-2025
– ON TRACK TO REPORT DATA FROM PHASE 1 CLINICAL TRIAL EVALUATING VG-3927 FOR THE TREATMENT OF ALZH...
Více zde
SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL)
09-10-2024
NEW YORK , OCT. 9, 2024 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING ...
Více zde
VIGIL NEUROSCIENCE ANNOUNCES FDA HAS REMOVED PARTIAL CLINICAL HOLD ON VG-3927
17-09-2024
WATERTOWN, MASS., SEPT. 17, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLIN...
Více zde
VIGIL NEUROSCIENCE TO PRESENT AT CANTOR GLOBAL HEALTHCARE CONFERENCE
16-09-2024
WATERTOWN, MASS., SEPT. 16, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLIN...
Více zde
VIGIL NEUROSCIENCE TO PRESENT AT UPCOMING SEPTEMBER INVESTOR CONFERENCES
29-08-2024
WATERTOWN, MASS., AUG. 29, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINI...
Více zde
SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL)
23-08-2024
NEW YORK , AUG. 23, 2024 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING...
Více zde
VIGIL NEUROSCIENCE REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
13-08-2024
- ANNOUNCED $40 MILLION STRATEGIC INVESTMENT FROM SANOFI; EXTENDED CASH RUNWAY INTO 2026 - - PROVIDE...
Více zde
VIGIL NEUROSCIENCE ANNOUNCES INTERIM DATA FROM ITS ONGOING PHASE 1 CLINICAL TRIAL EVALUATING VG-3927 IN HEALTHY VOLUNTEERS SUPPORTING CONTINUED DEVELOPMENT IN ALZHEIMER'S DISEASE
24-07-2024
- SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF VG-3927 SUPPORTS CONTINUED DE...
Více zde
VIGIL ANNOUNCES UPCOMING PRESENTATIONS ON ITS SMALL MOLECULE TREM2 AGONIST VG-3927 AT THE 2024 ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE
18-07-2024
WATERTOWN, MASS., JULY 18, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINI...
Více zde
VIGIL NEUROSCIENCE PROVIDES UPDATE ON CLINICAL DEVELOPMENT STRATEGY TO PURSUE POTENTIAL ACCELERATED APPROVAL PATHWAY FOR ILUZANEBART IN ALSP
18-07-2024
WATERTOWN, MASS., JULY 18, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINI...
Více zde
SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL)
08-07-2024
NEW YORK , JULY 8, 2024 /PRNEWSWIRE/ -- PURCELL & LEFKOWITZ LLP ANNOUNCES THAT IT IS INVESTIGATING ...
Více zde
VIGIL NEUROSCIENCE ANNOUNCES $40 MILLION STRATEGIC INVESTMENT FROM SANOFI
27-06-2024
- SANOFI TO INVEST $40 MILLION AT AN AS-CONVERTED PRICE OF $7.44 PER SHARE OF COMMON STOCK- - SANOFI...
Více zde
AUGUSTINE THERAPEUTICS RAISES EUR 17 MILLION IN A SERIES A FIRST CLOSING TO ADVANCE LEAD CANDIDATE INTO CLINICAL DEVELOPMENT IN NEUROLOGICAL DISEASES
26-06-2024
LEUVEN, BELGIUM--(BUSINESS WIRE)-- #ALS--AUGUSTINE THERAPEUTICS, A PIONEERING BIOTECH COMPANY FOCUSE...
Více zde
VIGIL NEUROSCIENCE TO PRESENT IN UPCOMING JUNE INVESTOR CONFERENCES
30-05-2024
WATERTOWN, MASS., MAY 30, 2024 (GLOBE NEWSWIRE) -- VIGIL NEUROSCIENCE, INC. (NASDAQ: VIGL), A CLINIC...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2025-08-05 01:00:00 | 8-K |  | Stáhnout |
| 2025-08-05 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-05 00:00:00 | 8-K | | Stáhnout |
| 2025-08-05 00:00:00 | 10-Q | | Stáhnout |
| 2025-07-28 01:00:00 | 8-K | | Stáhnout |
| 2025-07-28 00:00:00 | 8-K | | Stáhnout |
| 2025-07-17 01:00:00 | 8-K | | Stáhnout |
| 2025-07-17 00:00:00 | 8-K | | Stáhnout |
| 2025-05-23 01:00:00 | 8-K | | Stáhnout |
| 2025-05-23 00:00:00 | 8-K | | Stáhnout |
| 2025-05-22 01:00:00 | 8-K | | Stáhnout |
| 2025-05-22 00:00:00 | 8-K | | Stáhnout |
| 2025-05-07 01:00:00 | 8-K | | Stáhnout |
| 2025-05-07 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-07 00:00:00 | 8-K | | Stáhnout |
| 2025-05-07 00:00:00 | 10-Q | | Stáhnout |
| 2025-03-13 00:00:00 | 8-K | | Stáhnout |
| 2025-03-13 00:00:00 | 10-K | | Stáhnout |
| 2025-03-12 23:00:00 | 8-K | | Stáhnout |
| 2025-03-12 23:00:00 | 10-K | | Stáhnout |
| 2025-01-23 00:00:00 | 8-K | | Stáhnout |
| 2025-01-22 23:00:00 | 8-K | | Stáhnout |
| 2024-11-07 00:00:00 | 8-K | | Stáhnout |
| 2024-11-07 00:00:00 | 10-Q | | Stáhnout |
| 2024-11-06 23:00:00 | 8-K | | Stáhnout |
| 2024-11-06 23:00:00 | 10-Q | | Stáhnout |
| 2024-09-17 01:00:00 | 8-K | | Stáhnout |
| 2024-09-17 00:00:00 | 8-K | | Stáhnout |
| 2024-08-13 01:00:00 | 8-K | | Stáhnout |
| 2024-08-13 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-13 00:00:00 | 8-K | | Stáhnout |
| 2024-08-13 00:00:00 | 10-Q | | Stáhnout |
| 2024-07-24 01:00:00 | 8-K | | Stáhnout |
| 2024-07-24 00:00:00 | 8-K | | Stáhnout |
| 2024-07-18 01:00:00 | 8-K | | Stáhnout |
| 2024-07-18 00:00:00 | 8-K | | Stáhnout |
| 2024-06-27 01:00:00 | 8-K | | Stáhnout |
| 2024-06-27 00:00:00 | 8-K | | Stáhnout |
| 2024-06-06 01:00:00 | 8-K | | Stáhnout |
| 2024-06-06 00:00:00 | 8-K | | Stáhnout |
| 2024-05-07 01:00:00 | 8-K | | Stáhnout |
| 2024-05-07 01:00:00 | 10-Q | | Stáhnout |
| 2024-05-07 00:00:00 | 8-K | | Stáhnout |
| 2024-05-07 00:00:00 | 10-Q | | Stáhnout |
| 2024-03-26 00:00:00 | 8-K | | Stáhnout |
| 2024-03-26 00:00:00 | 10-K | | Stáhnout |
| 2024-03-25 23:00:00 | 8-K | | Stáhnout |
| 2024-03-25 23:00:00 | 10-K | | Stáhnout |
| 2024-01-11 00:00:00 | 8-K | | Stáhnout |
| 2024-01-10 23:00:00 | 8-K | | Stáhnout |
| 2023-11-16 00:00:00 | 8-K | | Stáhnout |
| 2023-11-15 23:00:00 | 8-K | | Stáhnout |
| 2023-11-07 00:00:00 | 8-K | | Stáhnout |
| 2023-11-07 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-06 23:00:00 | 8-K | | Stáhnout |
| 2023-11-06 23:00:00 | 10-Q | | Stáhnout |
| 2023-10-12 01:00:00 | 8-K | | Stáhnout |
| 2023-10-12 00:00:00 | 8-K | | Stáhnout |
| 2023-09-13 01:00:00 | 8-K | | Stáhnout |
| 2023-09-13 00:00:00 | 8-K | | Stáhnout |
| 2023-09-08 01:00:00 | 8-K | | Stáhnout |
| 2023-09-08 00:00:00 | 8-K | | Stáhnout |
| 2023-08-08 01:00:00 | 8-K | | Stáhnout |
| 2023-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-08 00:00:00 | 8-K | | Stáhnout |
| 2023-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2023-06-08 01:00:00 | 8-K | | Stáhnout |
| 2023-06-08 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 10-Q | | Stáhnout |
| 2023-05-10 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 00:00:00 | 10-Q | | Stáhnout |
| 2023-05-09 01:00:00 | 8-K | | Stáhnout |
| 2023-05-09 00:00:00 | 8-K | | Stáhnout |
| 2023-03-30 01:00:00 | 8-K | | Stáhnout |
| 2023-03-30 00:00:00 | 8-K | | Stáhnout |
| 2023-03-21 00:00:00 | 8-K | | Stáhnout |
| 2023-03-21 00:00:00 | 10-K | | Stáhnout |
| 2023-03-20 23:00:00 | 8-K | | Stáhnout |
| 2023-03-20 23:00:00 | 10-K | | Stáhnout |
| 2023-03-10 00:00:00 | 8-K | | Stáhnout |
| 2023-03-09 23:00:00 | 8-K | | Stáhnout |
| 2023-02-10 00:00:00 | 8-K | | Stáhnout |
| 2023-02-09 23:00:00 | 8-K | | Stáhnout |
| 2023-01-09 00:00:00 | 8-K | | Stáhnout |
| 2023-01-08 23:00:00 | 8-K | | Stáhnout |
| 2022-12-15 00:00:00 | 8-K | | Stáhnout |
| 2022-12-14 23:00:00 | 8-K | | Stáhnout |
| 2022-12-14 00:00:00 | 8-K | | Stáhnout |
| 2022-12-13 23:00:00 | 8-K | | Stáhnout |
| 2022-12-06 00:00:00 | 8-K | | Stáhnout |
| 2022-12-05 23:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 8-K | | Stáhnout |
| 2022-11-10 00:00:00 | 10-Q | | Stáhnout |
| 2022-11-09 23:00:00 | 8-K | | Stáhnout |
| 2022-11-09 23:00:00 | 10-Q | | Stáhnout |
| 2022-11-02 00:00:00 | 8-K | | Stáhnout |
| 2022-11-01 23:00:00 | 8-K | | Stáhnout |
| 2022-08-12 01:00:00 | 8-K | | Stáhnout |
| 2022-08-12 00:00:00 | 8-K | | Stáhnout |
| 2022-08-08 01:00:00 | 8-K | | Stáhnout |
| 2022-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-08 00:00:00 | 8-K | | Stáhnout |
| 2022-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2022-07-28 01:00:00 | 8-K | | Stáhnout |
| 2022-07-28 00:00:00 | 8-K | | Stáhnout |
| 2022-06-10 01:00:00 | 8-K | | Stáhnout |
| 2022-06-10 00:00:00 | 8-K | | Stáhnout |
| 2022-06-07 01:00:00 | 8-K | | Stáhnout |
| 2022-06-07 00:00:00 | 8-K | | Stáhnout |
| 2022-05-12 01:00:00 | 8-K | | Stáhnout |
| 2022-05-12 01:00:00 | 10-Q | | Stáhnout |
| 2022-05-12 00:00:00 | 8-K | | Stáhnout |
| 2022-05-12 00:00:00 | 10-Q | | Stáhnout |
| 2022-04-20 01:00:00 | 8-K | | Stáhnout |
| 2022-04-20 00:00:00 | 8-K | | Stáhnout |
| 2022-03-25 00:00:00 | 8-K | | Stáhnout |
| 2022-03-25 00:00:00 | 10-K | | Stáhnout |
| 2022-03-24 23:00:00 | 8-K | | Stáhnout |
| 2022-03-24 23:00:00 | 10-K | | Stáhnout |
| 2022-02-25 00:00:00 | 8-K | | Stáhnout |
| 2022-02-24 23:00:00 | 8-K | | Stáhnout |
| 2022-01-11 00:00:00 | 8-K | | Stáhnout |
| 2022-01-10 23:00:00 | 8-K | | Stáhnout |
